Device Thrombogenicty Emulator (DTE) – Design optimization Methodology for Cardiovascular Devices: A Study in Two Bileaflet MHV Designs

Patients who receive prosthetic heart valve (PHV) implants require mandatory anticoagulation medication after implantation due to the thrombogenic potential of the valve. Optimization of PHV designs may facilitate reduction of flow-induced thrombogenicity and reduce or eliminate the need for post-im...

詳細記述

保存先:
書誌詳細
主要な著者: Xenos, Michalis, Girdhar, Gaurav, Alemu, Yared, Jesty, Jolyon, Slepian, Marvin, Einav, Shmuel, Bluestein, Danny
フォーマット: Artigo
言語:Inglês
出版事項: 2010
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922449/
https://ncbi.nlm.nih.gov/pubmed/20483411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiomech.2010.04.020
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料